One technology platform to monitor both productivity and quality of biologics

Accelerate and de-risk upstream and downstream development

World´s first aggregation assay for any sample matrix

Analyze both purified or supernatant samples in real high-throughput

Screening assays
for critical glycan features

Cell culture supernatant screening possible

Titer assays for crude cell culture supernatants

Up to 384 samples
in 20 minutes

NEWS

November 6th 2020

Showcase presentation on HT Glycan Screening
 

Festival of Biologics - Virtual

NEWS

September 2020

PAIA launches Glycan Screening Services
for CLD and USP development

NEWS

July 2020

PAIA receives Eurostars grant for TIPQmed project
HT glycoscreening for targeted media optimization

NEWS

April 2020

Launch of second generation PA-104 Fc titer assay kit
with extended assay range